Data gathered: January 2
AI Stock Analysis - Axonics (AXNX)
Analysis generated July 22, 2024. Powered by Chat GPT.
Axonics is a healthcare technology company specializing in the development and commercialization of medical devices that treat urinary and bowel dysfunction. The company's focus on innovation and improving patients' quality of life has established it as a key player in the healthcare sector. Axonics operates in a competitive market but distinguishes itself with its cutting-edge technology and consistent product development efforts.
Stock Alerts - Axonics (AXNX)
 |
Axonics | December 3 Employee Rating is down by 2.6% over the last month. |
|
Axonics | November 20 Employee Rating is up by 2.7% over the last month. |
|
Axonics | November 13 Web Traffic is down by 30.6% over the last month. |
|
Axonics | October 23 Employee Rating is up by 2.8% over the last month. |
Alternative Data for Axonics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 5 | Sign up | Sign up | Sign up |
| Sentiment | 91 | Sign up | Sign up | Sign up |
| Webpage traffic | 68,000 | Sign up | Sign up | Sign up |
| Employee Rating | 76 | Sign up | Sign up | Sign up |
| Google Trends | 11 | Sign up | Sign up | Sign up |
| Patents | 57 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 3,168 | Sign up | Sign up | Sign up |
| Facebook Followers | 3,287 | Sign up | Sign up | Sign up |
| Instagram Followers | 4,222 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 548 | Sign up | Sign up | Sign up |
| Twitter Mentions | 40 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 3,050 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 79 | Sign up | Sign up | Sign up |
| Linkedin Employees | 700 | Sign up | Sign up | Sign up |
About Axonics
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction.
| Price | $70.98 |
| Target Price | Sign up |
| Volume | 4,170,000 |
| Market Cap | $3.63B |
| Year Range | $66.57 - $70.98 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Medical Devices |
In the news
 |
State Street Corp Sells 26,460 Shares of Axonics, Inc. (NASDAQ:AXNX)December 17 - ETF Daily News |
|
Axonics, Inc. (NASDAQ:AXNX) Given Average Recommendation of “Hold” by AnalystsDecember 9 - ETF Daily News |
|
Janus Henderson Group PLC Reduces Stock Position in Axonics, Inc. (NASDAQ:AXNX)December 9 - ETF Daily News |
|
Axonics, Inc. (NASDAQ:AXNX) Shares Acquired by Zurcher Kantonalbank Zurich CantonalbankDecember 7 - ETF Daily News |
|
Analysts Set Axonics, Inc. (NASDAQ:AXNX) PT at $71.00November 17 - ETF Daily News |
|
State of New Jersey Common Pension Fund D Purchases 1,379 Shares of Axonics, Inc. (NASDAQ:AXNX)November 17 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 116M | 110M | 90M | -21,000 | -4M | 0.000 |
| Q2 '24 | 115M | 99M | 89M | 6.9M | 5.9M | 0.130 |
| Q1 '24 | 91M | 100M | 69M | -19M | -17M | -0.380 |
| Q4 '23 | 110M | 99M | 83M | 6.6M | 3.3M | 0.130 |
| Q3 '23 | 93M | 86M | 69M | 3.9M | 1.6M | 0.080 |
Insider Transactions View All
| Keese Kari Leigh filed to sell 42,959 shares at $69.4. October 3 '24 |
| Keese Kari Leigh filed to sell 40,362 shares at $69.4. October 3 '24 |
| Keese Kari Leigh filed to sell 43,323 shares at $67.7. February 2 '24 |
| COHEN RAYMOND W filed to sell 188,835 shares at $67.7. February 2 '24 |
| Ford Alfred J Jr filed to sell 43,450 shares at $67.7. February 2 '24 |
Similar companies
Read more about Axonics (AXNX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Axonics?
The Market Cap of Axonics is $3.63B.
What is the current stock price of Axonics?
Currently, the price of one share of Axonics stock is $70.98.
How can I analyze the AXNX stock price chart for investment decisions?
The AXNX stock price chart above provides a comprehensive visual representation of Axonics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Axonics shares. Our platform offers an up-to-date AXNX stock price chart, along with technical data analysis and alternative data insights.
Does AXNX offer dividends to its shareholders?
As of our latest update, Axonics (AXNX) does not offer dividends to its shareholders. Investors interested in Axonics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Axonics?
Some of the similar stocks of Axonics are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.